China has approved a domestically developed radioactive imaging drug to help detect whether lung cancer has spread to lymph ...

Positive high-level results from the EMERALD-3 Phase III trial showed AstraZeneca's Imfinzi (durvalumab) in combination with Imjudo (tremelimumab ...

A young woman has told how an 18-month ordeal of constipation, vomiting and loss of appetite turned out to be advanced bowel ...

In some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth.

Passionate runner Martin Hull passed away in August last year after being diagnosed with lung cancer two weeks after he ...

Neoadjuvant chemoimmunotherapy demonstrated high pathological response rates with “manageable” toxicity in patients with squamous cell lung cancer, according to data presented at European Lung Cancer ...

When breast cancer spreads beyond the breast, it becomes much more dangerous. The lungs are one of the most common places ...

In some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical study with a 42-month-long follow-up period, researchers ...

Purdue University researcher Andrea Kasinski is leading work on the relationship between microRNAs — small, non-coding ...

Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck can ...

New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...

It can happen to anyone. Forty-eight-year-old Jennifer Brooks didn't think being out of breath would lead to a Stage 4 cancer ...